June 17, 2025

Dynavax Technologies Corporation (DVAX) Investor Outlook: Exploring a Potential 128.86% Upside

Dynavax Technologies Corporation (NASDAQ: DVAX) presents a compelling opportunity for investors in the healthcare sector, particularly within the specialized niche of vaccine development. With its focus..

Phreesia, Inc. (PHR) Investor Outlook: A 21.94% Upside Potential in Healthcare SaaS

Phreesia, Inc. (PHR) stands at the forefront of the Health Information Services industry, delivering a robust Software-as-a-Service (SaaS) platform that significantly enhances patient engagement and streamlines..

Enovis Corporation (ENOV) Stock Analysis: Exploring a 75% Potential Upside in the Medical Device Sector

Enovis Corporation (NYSE: ENOV), a prominent player in the healthcare sector, is capturing investor attention with a compelling potential upside of over 75%. With a market..

Amneal Pharmaceuticals (AMRX) Stock Analysis: Unpacking a 44.88% Potential Upside

Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) is making waves in the healthcare sector with a compelling potential upside of 44.88%, according to current analyst ratings. For investors..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Exploring a 13.89% Potential Upside Amid Valuation Challenges

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, commands a market capitalization of $3.17..

Guardian Pharmacy Services, Inc. (GRDN) Stock Analysis: Exploring a 38.40% Upside Potential

Guardian Pharmacy Services, Inc. (NYSE: GRDN), a leading player in the healthcare sector, is carving a niche in the medical care facilities industry with its innovative..

Kiniksa Pharmaceuticals, Ltd. (KNSA) Stock Analysis: Exploring a Potential 33.76% Upside

For investors seeking opportunities in the healthcare sector, Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) presents a compelling narrative. With a robust pipeline of innovative therapies targeting unmet..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: A 25.67% Potential Upside with Robust Revenue Growth

Alignment Healthcare, Inc. (NASDAQ: ALHC), a prominent player in the U.S. healthcare plans industry, is gaining traction among investors, buoyed by a promising 25.67% potential upside..

Biohaven Ltd. (BHVN) Stock Analysis: Exploring a 262.82% Potential Upside in the Biotech Sector

Biohaven Ltd. (NASDAQ: BHVN) has been making waves in the biotechnology sector, attracting significant attention from investors due to its promising pipeline and substantial upside potential...

Immunocore Holdings plc (IMCR) Stock Analysis: Exploring a Potential 88.94% Upside in the Biotech Arena

Immunocore Holdings plc (NASDAQ: IMCR) stands out in the competitive biotechnology sector, offering a fascinating proposition for investors with its potential 88.94% upside. As a commercial-stage..

89bio, Inc. (ETNB) Investor Outlook: Exploring a Potential 193% Upside with Innovative Biotech Solutions

89bio, Inc. (NASDAQ: ETNB) is capturing the attention of investors with a remarkable potential upside of 193.08%, according to analysts’ average target price of $29.45. As..

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: Exploring a 161% Potential Upside in the Biotech Space

Amicus Therapeutics, Inc. (NASDAQ: FOLD) is drawing the attention of investors with its substantial growth potential in the biotechnology sector. Specializing in treatments for rare diseases,..

Innoviva, Inc. (INVA) Stock Analysis: Exploring a 152% Potential Upside in the Biotech Sector

Innoviva, Inc. (NASDAQ: INVA) has garnered significant attention in the healthcare sector, particularly for its robust footprint within the biotechnology industry. With a market capitalization of..

Amphastar Pharmaceuticals, Inc. (AMPH): Investor Outlook with a Promising 24.71% Potential Upside

Investors eyeing the healthcare sector should take a closer look at Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a key player in the drug manufacturing industry, specializing in..

Omnicell, Inc. (OMCL) Stock Analysis: Uncovering a Potential 36% Upside for Investors

Omnicell, Inc. (NASDAQ: OMCL), a prominent player in the healthcare sector specializing in health information services, presents a compelling investment opportunity with an estimated 36.32% upside..

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Analysis: Potential 61% Upside Amid Robust Revenue Growth

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), a prominent player in the healthcare sector, is garnering significant attention from investors with its compelling growth prospects and strong analyst..

Evotec SE (EVO): Navigating a 45.71% Potential Upside in the Biotech Arena

Evotec SE (NASDAQ: EVO), a key player in the healthcare sector, operates as a drug discovery and development partner for the pharmaceutical and biotechnology industry on..

Recursion Pharmaceuticals (RXRX) Stock Analysis: Exploring a 42% Upside Potential

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) stands out in the biotechnology sector, not just for its innovative approach to drug discovery but also for its intriguing potential..

Mesoblast Limited (MESO): Investor Outlook and Potential 119% Upside – A Biotech Stock Worth Watching

Mesoblast Limited (NASDAQ: MESO), a Melbourne-based biotechnology company, has been capturing the attention of investors with its innovative approach to regenerative medicine. Specializing in mesenchymal lineage..

Pulse Biosciences, Inc (PLSE): Investor Outlook on the $1.03 Billion Bioelectric Medicine Pioneer

Pulse Biosciences, Inc. (NASDAQ: PLSE) is a company that has captured the attention of investors with its innovative approach to healthcare through bioelectric medicine. With a..

Search

Funds

June 17, 2025

Search

Funds

June 17, 2025

FTSE 100

Funds